Axsome Therapeutics (AXSM) Net Margin Growth (1y) (2023 - 2026)
Axsome Therapeutics (AXSM) Net Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | - |
| 10 | Axsome Therapeutics | 12.32 Bn | 12.02 Bn | 176.48 Mn | 1,516.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,516.00 |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 3,404.00 |
| Jun 30, 2025 | 5,905.00 |
| Mar 31, 2025 | 4,223.00 |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 4,596.00 |
| Jun 30, 2024 | 5,284.00 |
| Mar 31, 2024 | -7,926.00 |
| Dec 31, 2023 | 11,339.00 |
| Sep 30, 2023 | 15,845.00 |
| Jun 30, 2023 | 32,595.00 |